Official Announcement of Physiological Diagnostic Criteria for Vascular Failure from the Japanese Society for Vascular Failure
暂无分享,去创建一个
K. Kario | K. Node | C. Vlachopoulos | Teruo Inoue | Hiroshi Ito | S. Sugiyama | Y. Higashi | T. Kabutoya | H. Tomiyama | S. Ueda | M. Munakata | T. Maruhashi | Y. Matsuzawa | T. Miyoshi | Atsushi Tanaka | Teruo Inoue
[1] K. Kario,et al. Physiological Diagnostic Criteria for Vascular Failure. , 2018, Hypertension.
[2] P. Mäntyselkä,et al. Global arginine bioavailability ratio is decreased in patients with major depressive disorder. , 2018, Journal of affective disorders.
[3] G. He,et al. Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants , 2016, European journal of preventive cardiology.
[4] K. Kario,et al. Why the radial augmentation index is low in patients with diabetes: The J-HOP study. , 2016, Atherosclerosis.
[5] O. Wolkowitz,et al. Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation , 2016, Brain, Behavior, and Immunity.
[6] K. Kario,et al. Effects of Celiprolol and Bisoprolol on Blood Pressure, Vascular Stiffness, and Baroreflex Sensitivity. , 2015, American journal of hypertension.
[7] Daniel F. Freitag,et al. Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta-Analysis of 22 Prospective Studies , 2015, Journal of the American Heart Association.
[8] S. Laurent,et al. Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. , 2014, European heart journal.
[9] S. Kihara,et al. The elderly. , 2014, Journal of atherosclerosis and thrombosis.
[10] E. Lakatta,et al. Hypertension Derivation and Validation of Diagnostic Thresholds for Central Blood Pressure Measurements Based on Long-Term Cardiovascular Risks , 2022 .
[11] P. Segers,et al. Central Pulse Pressure and Its Hemodynamic Determinants in Middle-Aged Adults With Impaired Fasting Glucose and Diabetes , 2013, Diabetes Care.
[12] C. Jung,et al. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? , 2013, Cardiovascular research.
[13] S. Momomura,et al. Noninvasive estimation of central blood pressure and the augmentation index in the seated position: a validation study of two commercially available methods , 2013, Journal of hypertension.
[14] S. Hazen,et al. Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. , 2013, Journal of cardiac failure.
[15] R. Wolfe,et al. Arginine de novo and nitric oxide production in disease states. , 2012, American journal of physiology. Endocrinology and metabolism.
[16] T. Pieber,et al. Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[17] James D. Thomas,et al. Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1. , 2012, Journal of the American College of Cardiology.
[18] T. Ninomiya,et al. N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community: The Hisayama Study , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[19] K. Kohara,et al. Relatively lower central aortic pressure in patients with impaired insulin sensitivity and resistance: the Toon Health Study , 2011, Journal of hypertension.
[20] W. März,et al. Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. , 2011, Atherosclerosis.
[21] S. le Cessie,et al. Asymmetric Dimethylarginine (ADMA) Levels Display a Morning Peak in Patients with Acute Myocardial Infarction , 2011, Disease markers.
[22] Patrick Segers,et al. Ethnic Differences in Arterial Wave Reflections and Normative Equations for Augmentation Index , 2011, Hypertension.
[23] N. Girerd,et al. N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension , 2011, Hypertension.
[24] J. Danesh,et al. B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies , 2009, Circulation.
[25] Richard B Devereux,et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. , 2009, Journal of the American College of Cardiology.
[26] Stanley L Hazen,et al. Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks: Potential Mechanisms Beyond Nitric Oxide Synthase Inhibition , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[27] S. Morris,et al. Recent advances in arginine metabolism: roles and regulation of the arginases. , 2009, British journal of pharmacology.
[28] S. Hazen,et al. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. , 2009, Journal of the American College of Cardiology.
[29] Yasuhiko Tomino,et al. Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] K. Teraoka,et al. Synergistic effect of smoking and blood pressure on augmentation index in men, but not in women , 2009, Hypertension Research.
[31] B. Westerhof,et al. Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment , 2008, Journal of hypertension.
[32] S. Hazen,et al. Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction , 2007, Circulation.
[33] C. Moinard,et al. Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study , 2007, British Journal of Nutrition.
[34] L. Ignarro,et al. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. , 2007, Pharmacology & therapeutics.
[35] Kenji Takazawa,et al. Relationship between Radial and Central Arterial Pulse Wave and Evaluation of Central Aortic Pressure Using the Radial Arterial Pulse Wave , 2007, Hypertension Research.
[36] K. Node,et al. Vascular failure: a new clinical entity for vascular disease , 2006, Journal of hypertension.
[37] M. Sabatine,et al. Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation. , 2006, Circulation.
[38] M. Sabatine,et al. Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines. , 2006, Circulation.
[39] D. Kass,et al. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. , 2006, JAMA.
[40] A. Khoshdel,et al. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. , 2005, Journal of hypertension.
[41] J. Horowitz,et al. Determination of l-arginine and NG, NG - and NG, NG' -dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[42] J. Cooke. Asymmetrical Dimethylarginine: The Über Marker? , 2004, Circulation.
[43] J. Hochman,et al. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. , 2003, Circulation.
[44] A. García-Méndez,et al. Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: expression of the nitric oxide synthase isoforms. , 2002, Journal of the American College of Cardiology.
[45] F. Ohsuzu,et al. Morning attenuation of endothelium‐dependent, flow‐mediated dilation in healthy young men: Possible connection to morning peak of cardiac events? , 1999, Clinical cardiology.
[46] J. Cooke,et al. L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study , 1999, Vascular medicine.
[47] H. Hense,et al. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. , 1998, Journal of the American College of Cardiology.
[48] Guoyao Wu,et al. Arginine metabolism: nitric oxide and beyond. , 1998, The Biochemical journal.
[49] J P Cooke,et al. Nitric oxide synthase: role in the genesis of vascular disease. , 1997, Annual review of medicine.
[50] G. Ciliberto,et al. Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.
[51] J. Hodgson,et al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. , 1994, Journal of the American College of Cardiology.
[52] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[53] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[54] J. Laragh,et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. , 1984, Journal of the American College of Cardiology.
[55] W. Kannel,et al. The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.
[56] M. Litwin,et al. Guidelines for the Management of Hypertension , 2015 .
[57] G. Kimura,et al. Distribution of central blood pressure values estimated by Omron HEM-9000AI in the Japanese general population , 2013, Hypertension Research.
[58] J. Stockman. Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease , 2007 .
[59] L. Bolognini,et al. The radical cation of N,N-diethyl-para-phenylendiamine: A possible indicator of oxidative stress in biological samples , 2000 .
[60] K. Shimada,et al. Cross-sectional characterization of all classes of antihypertensives in terms of central blood pressure in Japanese hypertensive patients. , 2010, American journal of hypertension.